Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral allergen immunoprophylaxis for prevention of allergic sensitization and asthma
ACTRN12607000633482Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2006
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of House dust mite allergen extract, Allergenic Extract Standardized Cat Hair Acetone-Precipitated and timothy grass allergen extract in allergic rhinitis (AR) and asthma (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2006; status: recruiting.
02
Drugs
House dust mite allergen extractAllergenic Extract Standardized Cat Hair Acetone-Precipitatedtimothy grass allergen extract
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on ACTRN12607000633482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000633482.